Evidence map›Paper›PMID 38450161›Full record

ArticleFrontiers in microbiology2024

Oral

Mao Hagihara, Tadashi Ariyoshi, Shuhei Eguchi, Kentaro Oka, Motomichi Takahashi, Hideo Kato, Yuichi Shibata, Takumi Umemura, Takeshi Mori, Narimi Miyazaki and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. The combination ofmSystems · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Mao HagiharaDepartment of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute, Japan.
Tadashi AriyoshiR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.
Shuhei EguchiR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.
Kentaro OkaR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.
Motomichi TakahashiR&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.
Hideo KatoDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Yuichi ShibataDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Takumi UmemuraDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Takeshi MoriDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Narimi MiyazakiDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Jun HiraiDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Nobuhiro AsaiDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Nobuaki MoriDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Hiroshige MikamoDepartment of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.
Aichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometritis occurs frequently in humans and animals, which can negatively affect fertility and cause preterm parturition syndrome. Orally administered

Indexed as

Clostridium butyricumendometritisG protein-coupled receptor 120Lactobacillus speciesLimosilactobacillus speciesmetabolomemicrobiomeresolvin D5

Identifiers

PMID38450161
PMCPMC10915095
OpenAlexW4392001580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.